InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (37 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
37
T+90 hit rate
100%
T+90 mean return
+16.1%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Shanmugam Muthusamy, Chief Operating Officer. Director active across 1 company, notably ANI Pharmaceuticals INC. Aggregated, 47 reports have been recorded. Split: 1 buy · 37 sells. Total volume traded: €31.2m. Activity tracked since 17 March 2022. The latest transaction was disclosed on 26 February 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Shanmugam Muthusamy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations47 total
11,116 shares@ US$77.152.3% of flowCommon StockSEC:0001870913-26-000005:0
2,898 shares@ US$76.250.6% of flowCommon StockSEC:0001870913-26-000002:0
47,012 shares@ US$90.2711.7% of flowCommon StockSEC:0001870913-25-000008:0
47,010 shares@ US$89.4813.1% of flowCommon StockSEC:0001870913-25-000006:0
700 shares@ US$76.830.2% of flowCommon StockSEC:0001870913-25-000004:0
14,362 shares0Common StockSEC:0001870913-25-000002:0
9,574 shares0Common StockSEC:0001870913-25-000002:1
2,743 shares@ US$62.000.7% of flowCommon StockSEC:0001870913-24-000028:0
11,000 shares@ US$63.382.7% of flowCommon StockSEC:0001870913-24-000026:0
20,000 shares@ US$58.904.6% of flowCommon StockSEC:0001870913-24-000024:0
7,946 shares@ US$61.411.9% of flowCommon StockSEC:0001870913-24-000022:0
12,855 shares@ US$61.813.0% of flowCommon StockSEC:0001870913-24-000020:0
14,850 shares@ US$65.863.7% of flowCommon StockSEC:0001870913-24-000018:0
10,423 shares@ US$64.982.7% of flowCommon StockSEC:0001870913-24-000016:0
7,414 shares@ US$66.331.9% of flowCommon StockSEC:0001870913-24-000014:0
10,000 shares@ US$67.172.6% of flowCommon StockSEC:0001870913-24-000012:0
10,093 shares@ US$65.352.5% of flowCommon StockSEC:0001870913-24-000010:0
1,122 shares@ US$67.670.3% of flowCommon StockSEC:0001870913-24-000008:0
13,421 shares0Common StockSEC:0001870913-24-000006:0
4,524 shares@ US$55.571.0% of flowCommon StockSEC:0001870913-24-000004:0
5,692 shares@ US$55.951.2% of flowCommon StockSEC:0001870913-24-000004:1
15,000 shares@ US$56.443.2% of flowCommon StockSEC:0001870913-24-000004:2
5,000 shares@ US$55.631.1% of flowCommon StockSEC:0001870913-24-000002:0
11,974 shares@ US$52.442.4% of flowCommon StockSEC:0001870913-23-000020:0
13,026 shares@ US$52.442.6% of flowCommon StockSEC:0001870913-23-000020:1
25 of 47 declarations
About Shanmugam Muthusamy
Shanmugam Muthusamy is Head of R&D, COO-NOVITIUM OPS at ANI Pharmaceuticals INC (XNAS). He has 47 filings in total, and across the 47 sampled filings the reported transactions run from 2021-11-23 to 2026-03-02, with EUR 125433 of buys and EUR 31054374 of sells; the modal transaction nature is sell.
